Drug:
Reaction: OVERDOSE
20250101 - 20251231
No. 601 - 700
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 601 | 25726551 |
EU |
34 | 2 |
Drug dependence, Overdose, Product use in unapproved indication, Drug abuse, |
||||
GABAPENTIN, PREGABALIN, |
||||
| 602 | 25726553 |
EU |
50 | 2 |
Drug dependence, Overdose, |
||||
PREGABALIN, |
||||
| 603 | 25726566 |
US |
||
Hypoxia, Overdose, Toxicity to various agents, Weight decreased, Cardiac failure high output, Diarrhoea, Vomiting, Nausea, Headache, Flushing, Fatigue, Dyspnoea, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TADALAFIL, MACITENTAN, |
||||
| 604 | 25727472 |
US |
16 | 1 |
Overdose, |
||||
OXYCODONE HYDROCHLORIDE, ALPRAZOLAM, |
||||
| 605 | 25727583 |
US |
1 | |
Overdose, |
||||
OXYCODONE HYDROCHLORIDE, |
||||
| 606 | 25728806 |
US |
49 | 2 |
Overdose, |
||||
TIRZEPATIDE, |
||||
| 607 | 25728965 |
CA |
||
Aphthous ulcer, Condition aggravated, Erythema nodosum, Feeling abnormal, Malaise, Poor venous access, Sluggishness, Weight increased, Uveitis, Limb crushing injury, Drug level above therapeutic, Infusion site discharge, Fatigue, Hypertension, Illness, Arthralgia, Nasopharyngitis, Therapeutic response shortened, Inappropriate schedule of product administration, Drug ineffective, Off label use, Intentional product use issue, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, MEPERIDINE HYDROCHLORIDE, MEPERIDINE HYDROCHLORIDE, |
||||
| 608 | 25728982 |
US |
30 | 2 |
Blood thyroid stimulating hormone abnormal, Blindness, Overdose, Thyroid cancer metastatic, Off label use, |
||||
LEVOTHYROXINE SODIUM, |
||||
| 609 | 25730777 |
31 | 1 | |
Suicidal ideation, Overdose, Completed suicide, |
||||
FLUOXETINE HYDROCHLORIDE, FLUOXETINE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, ATOMOXETINE HYDROCHLORIDE, RISPERIDONE, BENZTROPINE MESYLATE, BENZTROPINE, |
||||
| 610 | 25719670 |
CA |
||
Haemoglobin decreased, Intentional product use issue, Off label use, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, |
||||
| 611 | 25719948 |
EU |
73 | |
Coma, Bezoar, Toxicity to various agents, Overdose, |
||||
QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, |
||||
| 612 | 25719991 |
EU |
21 | |
Overdose, |
||||
FLUOXETINE HYDROCHLORIDE, FLUOXETINE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, SODIUM NITRITE, |
||||
| 613 | 25720088 |
US |
21 | 1 |
Illness, Overdose, |
||||
TIRZEPATIDE, |
||||
| 614 | 25720100 |
CA |
||
Acne, Dermatitis acneiform, Rectal discharge, Skin hyperpigmentation, Anal haemorrhage, Eczema, Large intestinal stenosis, Pruritus, Off label use, Overdose, Intentional product use issue, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, AZATHIOPRINE, IRON, METHOTREXATE, METHOTREXATE SODIUM, UPADACITINIB, |
||||
| 615 | 25720405 |
CA |
||
Condition aggravated, Eye pain, Feeling abnormal, Liver disorder, Nephrolithiasis, Neuralgia, Ocular hypertension, Bronchitis, Constipation, Depression, Ear, nose and throat infection, Gastrointestinal microorganism overgrowth, Hypoaesthesia, Nasopharyngitis, Intentional product use issue, Off label use, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, |
||||
| 616 | 25720460 |
CA |
||
Condition aggravated, Drug ineffective, Off label use, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, |
||||
| 617 | 25720544 |
CA |
||
Ankylosing spondylitis, Condition aggravated, Osteopenia, Serum ferritin decreased, White blood cell count decreased, Off label use, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, MESALAMINE, MESALAMINE, RABEPRAZOLE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 618 | 25720624 |
CN |
30 | 2 |
Toxicity to various agents, Overdose, |
||||
IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 619 | 25720936 |
GB |
57 | 2 |
Acute kidney injury, Overdose, |
||||
PEMBROLIZUMAB, |
||||
| 620 | 25720955 |
EU |
13 | 1 |
Angina pectoris, Overdose, Toxicity to various agents, Somnolence, Dizziness, Tachycardia, Muscle twitching, Nausea, Abdominal pain upper, Accidental overdose, |
||||
PREGABALIN, |
||||
| 621 | 25721037 |
US |
2 | |
Oedema peripheral, Drug ineffective, Overdose, |
||||
IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 622 | 25721042 |
CA |
||
Basal cell carcinoma, Blister, Condition aggravated, Scratch, Umbilical hernia, Fatigue, Headache, Rash pruritic, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, AZATHIOPRINE, IRON, PREDNISONE, ROSUVASTATIN CALCIUM, |
||||
| 623 | 25721055 |
CA |
||
Condition aggravated, Drug level decreased, Arthralgia, Constipation, Hypertension, Off label use, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, PREDNISONE, PREDNISONE, |
||||
| 624 | 25721196 |
CA |
||
Abdominal distension, Breast tenderness, Increased appetite, Irritability, Vaginal haemorrhage, Dyspepsia, Fatigue, Pruritus, Rash, Urinary tract infection, Urticaria, Exposure during pregnancy, Inappropriate schedule of product administration, Incorrect dose administered, Intentional product use issue, Off label use, Overdose, Underdose, Intentional product use issue, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, |
||||
| 625 | 25721215 |
CA |
||
Arthritis, Arthropathy, Blood pressure systolic increased, Cough, Energy increased, Faecal calprotectin increased, Gingival pain, Joint injury, Muscular weakness, Oral pain, Oropharyngeal pain, Toothache, Weight decreased, Arthralgia, Dizziness, Drug specific antibody present, Fatigue, Psoriasis, Pyrexia, Tooth infection, Drug level below therapeutic, Inappropriate schedule of product administration, Intentional product use issue, Off label use, Therapeutic response unexpected, Intentional product use issue, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, FOLIC ACID, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 626 | 25721278 |
US |
59 | 2 |
Atrial fibrillation, Cardiac disorder, Drug ineffective, Overdose, Rheumatoid arthritis, Gait disturbance, Glucose tolerance impaired, Osteoarthritis, Glycosylated haemoglobin increased, Coronary artery occlusion, |
||||
LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM, LEVOTHYROXINE, |
||||
| 627 | 25721383 |
CA |
||
Asthenia, Blood pressure decreased, Vomiting, Condition aggravated, Decreased appetite, Pallor, Dizziness, Therapeutic product effect incomplete, Off label use, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, |
||||
| 628 | 25721486 |
IN |
||
Peripheral coldness, Hyperhidrosis, Chest pain, Dizziness, Overdose, |
||||
AMLODIPINE, |
||||
| 629 | 25721499 |
IN |
||
Cardiac arrest, Acute kidney injury, Capillary leak syndrome, Non-cardiogenic pulmonary oedema, Metabolic acidosis, Shock, Toxicity to various agents, Hyperhidrosis, Dizziness, Paraesthesia, Vomiting, Hypoaesthesia, Confusional state, Hypotension, Overdose, Drug ineffective, |
||||
AMLODIPINE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NOREPINEPHRINE (BITARTRATE), NOREPINEPHRINE, NOREPINEPHRINE BITARTRATE, VASOPRESSIN, VASOPRESSIN, CALCIUM GLUCONATE, EPINEPHRINE, ADRENALINUM, DEXTROSE MONOHYDRATE, DEXTROSE, SODIUM BICARBONATE, SODIUM BICARBONATE INJECTION,, FUROSEMIDE, |
||||
| 630 | 25722090 |
CA |
||
Condition aggravated, Therapeutic product effect incomplete, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, PREDNISONE, ROSUVASTATIN, |
||||
| 631 | 25726749 |
|||
Vomiting, Pyrexia, Toxicity to various agents, Hepatotoxicity, Renal impairment, Overdose, Analgesic drug level increased, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 632 | 25719137 |
US |
||
Overdose, |
||||
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 633 | 25718078 |
EU |
81 | 1 |
Respiratory failure, Pneumonia, Pneumonia, Pyrexia, Overdose, Intentional product use issue, |
||||
BEVACIZUMAB, BEVACIZUMAB, BEVACIZUMAB, CAPECITABINE, CAPECITABINE, CAPECITABINE, CAPECITABINE, AMLODIPINE BESYLATE, CANDESARTAN, CEFUROXIME, CEFUROXIME, LORAZEPAM, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, MIRTAZAPINE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, RAMIPRIL, RISPERIDONE, |
||||
| 634 | 25718152 |
CA |
||
Uveitis, Harvey-Bradshaw index increased, Off label use, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, |
||||
| 635 | 25718184 |
EU |
72 | 1 |
Hallucination, Confusional state, Aggression, Overdose, |
||||
FLUCONAZOLE, |
||||
| 636 | 25718312 |
US |
58 | 1 |
Melanocytic naevus, Off label use, Overdose, |
||||
TIRZEPATIDE, |
||||
| 637 | 25718577 |
CA |
||
Bone pain, Condition aggravated, Enteritis, Haemorrhage, Loose tooth, Nephrolithiasis, Pelvic pain, Phlebitis, Prinzmetal angina, Skin lesion, Weight decreased, Arthralgia, Back pain, Clostridium difficile infection, Constipation, Myocardial infarction, Nausea, Pyrexia, Urinary tract infection bacterial, Inappropriate schedule of product administration, Intentional product use issue, Maternal exposure timing unspecified, Off label use, Therapeutic product effect incomplete, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, ERENUMAB-AOOE, ERENUMAB-AOOE, LORAZEPAM, LORAZEPAM, PANTOPRAZOLE, PANTOPRAZOLE, PRAMIPEXOLE, PRAMIPEXOLE, RISEDRONATE SODIUM, RISEDRONATE SODIUM, RIZATRIPTAN, RIZATRIPTAN, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, ZOLMITRIPTAN, ZOLMITRIPTAN, |
||||
| 638 | 25718581 |
EU |
69 | 1 |
Neurotoxicity, Confusional state, Drug interaction, Myoclonus, Antiviral drug level above therapeutic, Blood creatinine increased, Drug level increased, Overdose, Encephalitis herpes, |
||||
MYCOPHENOLIC ACID, MYCOPHENILIC ACID, MYCOPHENOLIC ACID, MYCOPHENILIC ACID, MYCOPHENOLIC ACID, MYCOPHENILIC ACID, ACYCLOVIR, ACYCLOVIR, ACYCLOVIR, ACYCLOVIR, |
||||
| 639 | 25718939 |
EU |
85 | 2 |
Asthenia, Sinus bradycardia, Hypokalaemia, Hyponatraemia, Malaise, Overdose, |
||||
DIGOXIN, |
||||
| 640 | 25713074 |
CN |
37 | 1 |
Rash pruritic, Pyrexia, Overdose, |
||||
LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, |
||||
| 641 | 25713639 |
EU |
||
Cardiogenic shock, Cardiotoxicity, Overdose, |
||||
RITUXIMAB, DOXORUBICIN, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, PREDNISONE, VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR, SULFAMETHOXAZOLE AND TRIMETHOPRIM, LEUCOVORIN CALCIUM, FILGRASTIM, FILGRASTIM, |
||||
| 642 | 25713761 |
CN |
28 | 1 |
Retinal toxicity, Overdose, |
||||
SILDENAFIL CITRATE, SILDENAFIL, SILDENAFIL POWDER,, |
||||
| 643 | 25713762 |
GB |
56 | 1 |
Suicide attempt, Retinal toxicity, Overdose, Vision blurred, Visual field defect, |
||||
SILDENAFIL CITRATE, SILDENAFIL, SILDENAFIL POWDER,, |
||||
| 644 | 25713770 |
EU |
3 | 1 |
Unresponsive to stimuli, Loss of consciousness, Hypopnoea, Cyanosis, Respiratory depression, Toxicity to various agents, Overdose, Counterfeit product administered, |
||||
AMPHETAMINE, AMPHETAMINE SULFATE, AMPHETAMINE SULFATE TABLETS, OLANZAPINE, OXYCODONE HYDROCHLORIDE, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, PREGABALIN, SILDENAFIL CITRATE, SILDENAFIL, SILDENAFIL POWDER,, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, ALPRAZOLAM, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), |
||||
| 645 | 25713982 |
EU |
||
Bronchospasm, Dyspnoea, Hypoxia, Overdose, |
||||
INFLIXIMAB, PREDNISONE, FLUTICASONE FUROATE, MERCAPTOPURINE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 646 | 25714368 |
US |
64 | 1 |
Product administered at inappropriate site, Overdose, |
||||
| 647 | 25714592 |
US |
28 | 1 |
Ventricular tachycardia, Cardiac dysfunction, Electrocardiogram QRS complex prolonged, Electrocardiogram QT prolonged, Drug level increased, Overdose, Bradycardia, Toxicity to various agents, Generalised tonic-clonic seizure, Seizure, Sinus tachycardia, Mydriasis, Hypotension, Hypertension, |
||||
OLANZAPINE, BUPROPION, |
||||
| 648 | 25714642 |
SG |
||
Hyperammonaemia, Hyperammonaemic encephalopathy, Suicide attempt, Myoclonus, Overdose, |
||||
VALPROATE SODIUM, SERTRALINE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, ESTAZOLAM, |
||||
| 649 | 25714670 |
EU |
||
Dilated cardiomyopathy, Ejection fraction decreased, Overdose, Intentional product use issue, |
||||
TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, PERTUZUMAB, ADO-TRASTUZUMAB EMTANSINE, TUCATINIB, |
||||
| 650 | 25714746 |
EU |
||
Confusional state, Hallucination, Aggression, Overdose, |
||||
FLUCONAZOLE, |
||||
| 651 | 25714984 |
GB |
57 | 2 |
Acute kidney injury, Overdose, |
||||
LENVATINIB, PEMBROLIZUMAB, |
||||
| 652 | 25715135 |
EU |
32 | 2 |
Overdose, Vomiting, Hyperhidrosis, Abdominal pain, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 653 | 25715149 |
EU |
72 | 2 |
Overdose, Intentional overdose, Intentional overdose, Suicide attempt, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, SERTRALINE, LORAZEPAM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, LACOSAMIDE, |
||||
| 654 | 25715279 |
US |
85 | 1 |
Overdose, |
||||
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, MODAFINIL, MIRABEGRON, FAMOTIDINE, LISINOPRIL, GABAPENTIN, TEMAZEPAM, TOLTERODINE TARTRATE, TOLTERODINE, FINASTERIDE, DOXEPIN, DOXEPIN HYDROCHLORIDE, |
||||
| 655 | 25715354 |
US |
23 | 2 |
Resuscitation, Endotracheal intubation, Overdose, |
||||
OXYCODONE, ALPRAZOLAM, FENTANYL, QUININE, |
||||
| 656 | 25716524 |
EU |
51 | 1 |
Overdose, Depressed level of consciousness, Toxicity to various agents, |
||||
PREGABALIN, |
||||
| 657 | 25716615 |
CN |
70 | 2 |
Altered state of consciousness, Miosis, Overdose, |
||||
OXYCODONE HYDROCHLORIDE, OXYCODONE, |
||||
| 658 | 25716847 |
CA |
40 | 2 |
Systemic lupus erythematosus, Drug hypersensitivity, Rash, Off label use, Infusion related reaction, Ill-defined disorder, Wound, Injection site reaction, Nausea, Dyspnoea, Rheumatic fever, C-reactive protein abnormal, Onychomadesis, Contraindicated product administered, Psoriatic arthropathy, Confusional state, Pain, Pemphigus, Drug ineffective, Onychomycosis, C-reactive protein increased, Pericarditis, Intentional product use issue, Treatment failure, Underdose, Product use issue, Therapeutic product effect incomplete, Sleep disorder, Swelling, Overdose, Type 2 diabetes mellitus, Synovitis, Therapeutic product effect decreased, Product use in unapproved indication, Rheumatoid arthritis, |
||||
DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, BOTULINUM TOXIN TYPE A, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ERENUMAB-AOOE, ERENUMAB-AOOE, ERENUMAB-AOOE, ERENUMAB-AOOE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, CANDESARTAN CILEXETIL, PHENYLEPHRINE HYDROCHLORIDE, GOLIMUMAB, GOLIMUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, HYDROCORTISONE SODIUM SUCCINATE, HYDROCORTISONE SODIUM SUCCINATE, TRAMADOL HYDROCHLORIDE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, THIAMINE HYDROCHLORIDE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, BUPRENORPHINE, BUPRENORPHINE, LAMOTRIGINE, LAMOTRIGINE, APREMILAST, APREMILAST, APREMILAST, APREMILAST, APREMILAST, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, ATOMOXETINE HYDROCHLORIDE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, CALCIUM CARBONATE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, RAMIPRIL, RAMIPRIL, RAMIPRIL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, OXYCODONE, DESOGESTREL AND ETHINYL ESTRADIOL, HYDROXYCHLOROQUINE SULFATE, MIRABEGRON, MIRABEGRON, ADALIMUMAB, ADALIMUMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, NEOMYCIN SULFATE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, AZATHIOPRINE, MINOCYCLINE HYDROCHLORIDE, MEPOLIZUMAB, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, HYDROCORTISONE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CELECOXIB, CELECOXIB, DIATRIZOATE MEGLUMINE, CORTISONE ACETATE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ERGOCALCIFEROL, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, RANITIDINE HYDROCHLORIDE, DICLOFENAC SODIUM, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, |
||||
| 659 | 25716949 |
EU |
34 | 1 |
Cardiac failure, Toxicity to various agents, Hepatic cytolysis, Rhabdomyolysis, Multiple organ dysfunction syndrome, Pulmonary oedema, Renal failure, Drug interaction, Drug level increased, Cough, Dyspnoea, General physical health deterioration, Haemoptysis, Leukocytosis, Lymphopenia, Diarrhoea, Acute respiratory failure, Left ventricular failure, Overdose, |
||||
HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, COLCHICINE, COLCHICINE, COLCHICINE, COLCHICINE, COLCHICINE, CYCLOSPORINE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, COLISTIMETHATE SODIUM, COLISTIMETHATE SODIUM, CYCLOSPORINE, CYCLOSPORINE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, EVEROLIMUS, EVEROLIMUS TABLETS, EVEROLIMUS, EVEROLIMUS TABLETS, IRBESARTAN, IRBESARTAN, CALCIUM, |
||||
| 660 | 25716955 |
EU |
72 | 1 |
Confusional state, Aggression, Hallucination, Overdose, |
||||
FLUCONAZOLE, |
||||
| 661 | 25717935 |
59 | 1 | |
Alopecia, Mucosal inflammation, Nausea, Neuropathy peripheral, Fatigue, Diarrhoea, Cellulitis, Dyspepsia, Rhinalgia, Off label use, Leukocytosis, Leukopenia, Platelet count decreased, Disease progression, Neoplasm progression, Lymphocyte count abnormal, Lymphocyte count decreased, Neutropenia, Delusion of grandeur, Hallucination, auditory, Neutrophil count increased, Thrombocytopenia, Incorrect dose administered, Neutrophil count decreased, Extrapyramidal disorder, Affective disorder, Psychotic disorder, Schizophrenia, Seizure, Overdose, Intentional product misuse, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, OLANZAPINE, OLANZAPINE, OLANZAPINE, OLANZAPINE, OLANZAPINE, OLANZAPINE, OLANZAPINE, PACLITAXEL, PACLITAXEL, PACLITAXEL, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, CHLORPROMAZINE, CHLORPROMAZINE, CHLORPROMAZINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, LITHIUM, LITHIUM BROMATUM, LITHIUM, LITHIUM BROMATUM, LITHIUM, LITHIUM BROMATUM, LITHIUM, LITHIUM BROMATUM, LORAZEPAM, LORAZEPAM, LORAZEPAM, PERTUZUMAB, PERTUZUMAB, PERTUZUMAB, PERTUZUMAB, PERTUZUMAB, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, DENOSUMAB, RANITIDINE, RANITIDINE, RANITIDINE, CHLORPHENIRAMINE MALEATE, DENOSUMAB, DENOSUMAB, DULOXETINE HYDROCHLORIDE, DULOXETINE, GENTAMICIN, GENTAMICIN SULFATE, MIRTAZAPINE, MIRTAZAPINE, MORPHINE, MORPHINE, MORPHINE SULFATE, MORPHINE SULFATE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, PREGABALIN, PREGABALIN, PREGABALIN, |
||||
| 662 | 25718195 |
CA |
40 | 2 |
Decreased appetite, Hypersensitivity, Injury, Insomnia, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Live birth, Liver function test increased, Liver injury, Lower respiratory tract infection, Lung disorder, Malaise, Memory impairment, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Muscular weakness, Musculoskeletal stiffness, Nail disorder, Nasopharyngitis, Nausea, Neck pain, Night sweats, Obesity, Onychomadesis, Onychomycosis, Osteoarthritis, Pain, Pain in extremity, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Pneumonia, Psoriatic arthropathy, Rash, Rheumatic fever, Rheumatoid arthritis, Sleep disorder, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Taste disorder, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Wheezing, Wound, Wound infection, Therapeutic product effect decreased, Treatment failure, Maternal exposure during pregnancy, Overdose, Underdose, Intentional product use issue, Product label confusion, Product use in unapproved indication, Off label use, Product quality issue, |
||||
APREMILAST, ERENUMAB-AOOE, APREMILAST, CELECOXIB, CELECOXIB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, GOLIMUMAB, GOLIMUMAB, AZATHIOPRINE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NICOTINAMIDE, MEPOLIZUMAB, OXYCODONE, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, PHENYLEPHRINE HYDROCHLORIDE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RAMIPRIL, RAMIPRIL, RAMIPRIL, RANITIDINE HYDROCHLORIDE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, SULFASALAZINE, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOFACITINIB, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TRAMADOL HYDROCHLORIDE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, |
||||
| 663 | 25718349 |
EU |
43 | |
Drug abuse, Pharmaceutical nomadism, Overdose, Illicit prescription attainment, |
||||
ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, ALPRAZOLAM, |
||||
| 664 | 25708483 |
US |
||
Overdose, |
||||
ADALIMUMAB-ADAZ, |
||||
| 665 | 25708504 |
US |
26 | 1 |
Endotracheal intubation, Incontinence, Overdose, Vomiting, |
||||
MORPHINE, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), HYDROXYZINE, |
||||
| 666 | 25708719 |
EU |
||
Decreased appetite, General physical health deterioration, Overdose, |
||||
BEVACIZUMAB, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, OXYCODONE HYDROCHLORIDE, OXYCODONE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, OXYCODONE HYDROCHLORIDE, |
||||
| 667 | 25708991 |
US |
40 | 1 |
Ischaemic stroke, Overdose, Bradycardia, Urine output decreased, Hypertransaminasaemia, Metabolic acidosis, Hypoperfusion, Right ventricular dysfunction, Left ventricular dysfunction, Toxicity to various agents, Cardiogenic shock, Cerebral haemorrhage, |
||||
METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, |
||||
| 668 | 25709018 |
US |
40 | 1 |
Cardiogenic shock, Overdose, Bradycardia, |
||||
FLUOXETINE HYDROCHLORIDE, METOPROLOL TARTRATE, METOPROLOL, |
||||
| 669 | 25709145 |
US |
2 | 1 |
Unresponsive to stimuli, Sinus tachycardia, Nystagmus, Slow response to stimuli, Mental status changes, Mydriasis, Ataxia, Stupor, Drooling, Dyskinesia, Asthenia, Staring, Somnolence, Sedation, Toxicity to various agents, Eye movement disorder, Lethargy, Hypotonia, Product use issue, Accidental exposure to product, Overdose, Vomiting, |
||||
DEXTROMETHORPHAN HYDROBROMIDE AND GUAIFENESIN, CAMPHOR (NATURAL), EUCALYPTUS OIL, AND MENTHOL, UNSPECIFIED FORM, DEXTROMETHORPHAN, ACETAMINOPHEN AND DEXTROMETHORPHAN HYDROBROMIDE, |
||||
| 670 | 25709332 |
IN |
||
Cardiac arrest, Metabolic acidosis, Shock, Acute kidney injury, Pulmonary oedema, Overdose, Toxicity to various agents, Hyperhidrosis, Paraesthesia, Hypoaesthesia, Dizziness, Vomiting, |
||||
AMLODIPINE, |
||||
| 671 | 25709370 |
US |
71 | 2 |
Overdose, Cardiorenal syndrome, Dyspnoea, Cardiac failure, Hypoxia, Drug ineffective, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TADALAFIL, MACITENTAN, |
||||
| 672 | 25709416 |
JP |
76 | 2 |
Herpes zoster, Physical deconditioning, Muscle spasms, Overdose, |
||||
ABALOPARATIDE, |
||||
| 673 | 25709759 |
US |
79 | 1 |
Underdose, Overdose, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 674 | 25709855 |
US |
||
Toxicity to various agents, Sinus bradycardia, Overdose, Hypotension, Hypertension, |
||||
DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, FENTANYL, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, MAXIMUM STRENGTH PAIN RELIEVER, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, QUININE, |
||||
| 675 | 25709862 |
US |
||
Toxicity to various agents, Sinus bradycardia, Overdose, |
||||
DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, FENTANYL, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, MAXIMUM STRENGTH PAIN RELIEVER, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, |
||||
| 676 | 25709864 |
US |
||
Sinus bradycardia, Toxicity to various agents, Overdose, Hypertension, |
||||
DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, FENTANYL, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, MAXIMUM STRENGTH PAIN RELIEVER, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), TEMAZEPAM, |
||||
| 677 | 25709865 |
US |
||
Toxicity to various agents, Overdose, Sinus bradycardia, Hypotension, |
||||
DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, FENTANYL, OXYCODONE, MIRTAZAPINE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, SERTRALINE, HYDROXYZINE, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, |
||||
| 678 | 25710064 |
EU |
15 | 2 |
Pallor, Somnolence, Overdose, Product appearance confusion, Dizziness, |
||||
NICOTINE POLACRILEX, |
||||
| 679 | 25710127 |
EU |
21 | 2 |
Overdose, Methaemoglobinaemia, |
||||
IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, SODIUM NITRITE, |
||||
| 680 | 25710365 |
US |
2 | |
Peripheral swelling, Joint swelling, Overdose, |
||||
MINOXIDIL, |
||||
| 681 | 25710435 |
US |
2 | |
Overdose, |
||||
FENTANYL, FENTANYL, FENTANYL, FENTANYL, |
||||
| 682 | 25711503 |
US |
||
Cerebrospinal fluid leakage, Post lumbar puncture syndrome, Blood pressure increased, Dyspnoea, Nerve injury, Pain, Vomiting, Dysuria, Overdose, No adverse event, |
||||
ZICONOTIDE ACETATE, FENTANYL, HYDROMORPHONE HYDROCHLORIDE, |
||||
| 683 | 25711620 |
EU |
73 | |
Coma, Toxicity to various agents, Bezoar, Overdose, |
||||
QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, |
||||
| 684 | 25711658 |
CA |
2 | |
Maternal exposure during pregnancy, Food allergy, Headache, Hepatic enzyme increased, Hyperhidrosis, Hypersensitivity, Hypertension, Immunodeficiency, Infusion related reaction, Intentional product misuse, Joint swelling, Off label use, Overdose, Pain, Prescribed overdose, Product use issue, |
||||
RITUXIMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, |
||||
| 685 | 25712041 |
US |
44 | 2 |
Application site acne, Application site pruritus, Overdose, |
||||
MINOXIDIL, |
||||
| 686 | 25712235 |
US |
||
Fall, Dizziness, Overdose, Product communication issue, |
||||
DEXTROMETHORPHAN HYDROBROMIDE, BUPROPION HYDROCHLORIDE, |
||||
| 687 | 25712711 |
US |
1 | |
Death, Overdose, Drug dependence, Drug abuse, |
||||
OXYCODONE HYDROCHLORIDE, |
||||
| 688 | 25703328 |
CA |
||
Aphthous ulcer, Cataract, Condition aggravated, Malaise, Oropharyngeal pain, Proctalgia, Productive cough, Rectal haemorrhage, Drug level above therapeutic, Drug level decreased, Bacterial infection, Bacteraemia, Bacteriuria, COVID-19, Pyrexia, Urinary tract infection, Intentional product use issue, Off label use, Overdose, Intentional product use issue, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, AZATHIOPRINE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, PANTOPRAZOLE, MESALAMINE, PREDNISONE, SEMAGLUTIDE, |
||||
| 689 | 25703337 |
US |
1 | |
Incorrect dose administered, Product dose omission issue, Overdose, Dyspnoea, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 690 | 25703340 |
CA |
||
Condition aggravated, Pain, Therapeutic response shortened, Drug ineffective, Inappropriate schedule of product administration, Off label use, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, PREDNISONE, |
||||
| 691 | 25703352 |
CA |
||
Arthritis, Condition aggravated, Drug level above therapeutic, Faecal calprotectin increased, Vitamin D decreased, Arthralgia, Nasopharyngitis, Off label use, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, FOLIC ACID, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 692 | 25703386 |
CA |
||
Condition aggravated, Drug level below therapeutic, Hypertension, Inappropriate schedule of product administration, Off label use, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, MAGNESIUM, PANTOPRAZOLE, |
||||
| 693 | 25703410 |
CA |
||
Food poisoning, Nasal ulcer, Skin disorder, Skin lesion, Epistaxis, Headache, Immunodeficiency, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, |
||||
| 694 | 25703423 |
CA |
||
Condition aggravated, Transient ischaemic attack, Pneumonia, Inappropriate schedule of product administration, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, FOLIC ACID, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 695 | 25703453 |
US |
2 | |
Wrong technique in device usage process, Overdose, |
||||
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 696 | 25703476 |
CA |
||
Condition aggravated, Hip arthroplasty, Sleep apnoea syndrome, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, |
||||
| 697 | 25703483 |
CA |
||
Condition aggravated, Infusion site extravasation, Poor venous access, Neuralgia, Arthralgia, Lupus-like syndrome, Paraesthesia, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, MESALAMINE, METHOTREXATE, METHOTREXATE SODIUM, MESALAMINE, PREDNISONE, |
||||
| 698 | 25703526 |
CA |
||
Condition aggravated, Anal fissure, Aphthous ulcer, Blood iron decreased, Fall, Road traffic accident, Limb injury, Erythema nodosum, Mouth ulceration, Peripheral swelling, Cough, Pain in extremity, Nasopharyngitis, Rash erythematous, Vertigo, Nausea, Pyrexia, Overdose, Underdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, SULFASALAZINE, |
||||
| 699 | 25703529 |
CA |
||
Poor venous access, Condition aggravated, Rales, Pallor, Heart rate increased, Arthralgia, Influenza, Nasopharyngitis, Pneumonia, Intentional product use issue, Off label use, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, CLONAZEPAM, DULOXETINE HYDROCHLORIDE, FOLIC ACID, OLANZAPINE, |
||||
| 700 | 25703531 |
CA |
55 | 1 |
Cerebral venous sinus thrombosis, Altered state of consciousness, Hemiparesis, Piloerection, Anaemia, Myalgia, Arthralgia, Diarrhoea, Withdrawal syndrome, Overdose, |
||||
FENTANYL CITRATE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-10-30